clinical trial · NCT04102943
Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.
Kidney Transplanttacrolimus tablettacrolimus capsules
brief summary
The purpose of this study is to evaluate the pharmacokinetics and tolerability of Tacrolimus tablet(TacroBell) in kidney transplant recipients.
started
Nov 30, 2017
primary completion
Sep 29, 2020
completion
Sep 29, 2020
last updated
Apr 15, 2026
detailed description
This study is a Single center, randomized, open-label, Phase IV study to evaluate the pharmacokinetics and tolerability of Tacrolimus tablet(TacroBell) administration for 24 Weeks in patients after renal transplantation.
official title
Single Center, Randomized, Open-label, Phase IV Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus Tablet(TacroBell) in Kidney Transplant Recipients.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol